Las células T inmunitarias aún pueden luchar contra las variantes de la COVID, ¿pero por cuánto tiempo?
LUNES, 5 de diciembre de 2022 (HealthDay News) — Aunque las células T del sistema inmunitario de las personas todavía pueden atacar a las proteínas de pico del coronavirus de la COVID, su capacidad de hacerlo está menguando con el tiempo, informan un…
Learn More41.6 Percent of Adults Have Serology Indicative of Past COVID-19 Infection
MONDAY, Dec. 5, 2022 (HealthDay News) — More than 40 percent of U.S. adults have serology indicative of past COVID-19 infection, of whom 43.7 percent report never having had COVID-19, according to research published in the Dec. 2 issue of the U.S. C…
Learn MoreFeds Urge Vaccination as ‘Tripledemic’ Hits More Americans
MONDAY, Dec. 5, 2022 (HealthDay News) — Flu, respiratory syncytial virus (RSV), and COVID-19 are creating a perfect storm of respiratory disease that is overwhelming the nation’s health care systems.Vaccination will be key to patients getting through…
Learn MorePfizer Asks FDA to Approve Tweaked COVID-19 Booster as Third Shot for Under 5s
MONDAY, Dec. 5, 2022 (HealthDay News) — Infants and young children could soon receive an updated COVID-19 vaccine as part of their three-dose series.Pfizer Inc. on Monday asked the U.S. Food and Drug Administration to have the vaccine that targets th…
Learn MoreFDA: No Useful Monoclonal Antibody Treatments Left Against New COVID-19 Variants
MONDAY, Dec. 5, 2022 (HealthDay News) — The last of six COVID-19 monoclonal antibody treatments has lost its federal authorization because, like the others, it no longer works against the newest omicron subvariants.This last monoclonal antibody was b…
Learn MoreFeds Urge Vaccination as ‘Tripledemic’ Hits More Americans
MONDAY, Dec. 5, 2022 (HealthDay News) — Flu, RSV and COVID-19 are creating a perfect storm of respiratory disease that is overwhelming the nation’s health care systems.Vaccination will be key to getting through the winter holidays with your health in…
Learn MorePfizer Asks FDA to Approve Tweaked COVID Booster as Third Shot for Kids Under 5
MONDAY, Dec. 5, 2022 (HealthDay News) — Infants and young children could soon receive an updated COVID-19 vaccine as part of their three-dose series. Pfizer Inc. on Monday asked the U.S. Food and Drug Administration to have the vaccine that targets t…
Learn MoreDynamically Updating Models Can Improve Prediction of COVID-19 Survival
MONDAY, Dec. 5, 2022 (HealthDay News) — Dynamically updating models can improve prediction of 28-day survival in hospitalized COVID-19 patients, according to a study published online Nov. 10 in Nature Communications.Todd J. Levy, from the Feinstein I…
Learn MoreThere Are No Useful Monoclonal Antibody Treatments Left Against New COVID Variants
MONDAY, Dec. 5, 2022 (HealthDay News) — The last of six COVID monoclonal antibody treatments has lost its federal authorization because, like the others, it no longer works against the newest Omicron subvariants.This last monoclonal antibody was bebt…
Learn More‘COVID-somnia’ May Be Easing as Americans Report Better Sleep
MONDAY, Dec. 5, 2022 (HealthDay News) — Finally, more than two years into the pandemic, Americans are sleeping better. A new survey from the American Academy of Sleep Medicine (AASM) found that 31% of people have had insomnia since the pandemic began…
Learn More